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In the United States, the current cases of Alzheimer’s disease will double by 2050. 
Therefore, it is important to study risk factors associated with dementia such as sleep duration. 
This meta-analysis was conducted to understand the discrepancy in study results since some 
demonstrated a V shaped association between duration of sleep and dementia while others 
found no association. If there truly is an association then sleep duration could be targeted to 
decrease the burdens caused by dementia.  
A meta-analysis of published studies was conducted to assess the association between 
sleep duration and the different forms of dementia. The articles were found using PubMed, 
Embase, Scopus, and EBSCO with the search terms (“Sleep Duration” OR “Change in Sleep 
Duration”) AND (Alzheimer* OR Dementia) and reviewing bibliographies. Studies were 
included in the analysis if they met the following criteria 1) a longitudinal study 2) a cohort, 
case-control, or clinical trial 3) assessed the exposure and outcome of interest 4) diagnosed 
dementia using established diagnostic criteria 5) provided a risk estimate and 95% confidence 
interval (CI) 6) in English 7) a published paper. Analyses such as test of heterogeneity, 
sensitivity analysis, and tests of publication bias were done using STATA15.  
The analysis included 11 cohort studies with a total of 48,360 participants. No significant 
  
association was found between short or long sleep duration and any form of dementia. 
However, there was a significant association between increase in sleep and dementia but there 
were only two published papers that examined this association.  This study suggests that there is 
likely no association between sleep duration and any form of dementia which differs from 
results of previous meta-analyses. 
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BACKGROUND  
 
Dementia is a general disease category used to describe degenerative brain diseases, 
such as Alzheimer’s disease and vascular dementia, which affect the elderly population 
(Gatz, et al., 2010). While the risk of Alzheimer’s disease is only 8-10% in those age 60-69 
years old it triples to 33-38% at age 80 years for those who are carriers of the apolipoprotein 
E (APOE) 4allele, the genetic variant that has been associated with an increased risk of 
Alzheimer’s disease (Rasmussen, et al., 2018). Alzheimer’s disease is characterized by a 
steady decline of memory and cognitive ability to the point that it interferes with daily 
activity, while the biological characteristics are the accumulation of extracellular beta-
amyloid plaques and tau proteins in the brain. Vascular dementia differs from other forms of 
dementia because there must be evidence that the cognitive decline is due to vascular 
changes such as stroke (American Psychiatric Association, 2013). Those with vascular 
dementia are more likely to live with more activities of daily living limitations than those 
with Alzheimer’s disease (Gure, et al., 2009). While there are several biomarkers and 
imaging techniques that can be used in the research setting to help diagnose dementia a 
definite confirmation can only be done after death by dissecting the brain (Scheltens, et al., 
2016). 
In the United States, it is estimated that there are around 5.7 million cases of dementia 
with 60-70% of cases being categorized as Alzheimer’s disease dementia and 5-10% of cases 
being categorized as vascular dementia. Due to the increase in life expectancy, it is expected 
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that the number of people with dementia or Alzheimer’s disease will double to around 13.8 
million in 2050 (Hebert, et al., 2013).  
Unfortunately, since there is no cure for dementia it is ultimately fatal. In 2014, 
Alzheimer’s disease was the sixth leading cause of death in the United States with a mortality 
rate of 25.4 deaths per 100,000 people. (Taylor, et al., 2017). As a result, it is important to 
study and validate risk factors that could potentially be targeted to reduce the risk for 
dementia. There are several known modifiable risk factors for dementia such as being 
diabetic (Akomolafe, et al., 2006), obese (Whitmer, et al., 2007), having hypertension 
(Skoog, et al., 1996), a history of cardiovascular disease (Eriksson, et al., 2010), and low 
education (Gatz, et al., 2007). Recently, the role of sleep has been gaining attention as a 
potential risk factor for cognitive disorders.  
Sleep has become a behavioral risk factor of interest because around one third of 
adults report having sleep issues such as experiencing symptoms of insomnia, abnormal sleep 
durations, and non-restorative sleep, making this a relatively common risk factor in the 
United States (Morin, et al., 2006). The elderly population is the most likely to complain 
about sleep disturbances, with the highest reported prevalence estimated at 70% (Jaussent, et 
al., 2011). It has become a risk factor of interest for dementia and Alzheimer’s disease since 
around 45% of those with the disease have a type of sleeping disturbance and 25-44% have a 
type of sleeping disorder (Morin, et al., 2006). The development of sleeping disorders and 
changes in sleep patterns are part of the natural aging process just like cognitive decline. 
Thus, researchers have been trying to understand if they simply co-exist with one another or 
if one precedes the other. (Shi, et al., 2018). 
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The relationship between sleep duration and dementia has been gaining attention.  
This is because earlier studies have linked short and long duration of sleep to risk factors 
associated with dementia such as cardiovascular disease (Cappuccio, et al., 2011), diabetes 
mellitus (Gottlieb, et al., 2005), and obesity (Gangwish, et al., 2005). There are several 
studies that have demonstrated a V shaped association between duration of sleep and 
cognitive disorders such as dementia or Alzheimer’s disease. This suggests that elderly 
individuals who have longer or shorter duration of sleep are more likely to develop a 
cognitive disorder than those who have average duration of sleep. (Chen, et al., 2015) 
However, there are some studies which only found an association for short duration of sleep 
(Potvin, et al., 2012), others only found an association for long duration of sleep (Benito-
Leon, et al., 2009), and some even observed no association (Luojus, et al., 2017) between 
duration of sleep and cognition. The direction of effect is also not consistent with some 
studies finding that shorter duration of sleep was protective for dementia (Sindi, et al., 2009).  
Review of Prior Studies 
There are currently only three meta-analyses published, with the most recent of these 
published in 2018 and including articles through 2017 (Kim, et al., 2016: Liang & Ling-Bo & 
Hao, 2018: Wu & Sun & Tan, 2018). The methods of measuring duration of sleep in 
published studies is through self-report or questionnaires. Dementia and Alzheimer’s disease 
were normally measured based on standardized criteria such as the Diagnostic and Statistical 
Manual of Mental Disorders, Fourth Edition (DSM-IV) (Wu & Sun & Tan, 2018). The 
DSM-IV defines dementia of the Alzheimer’s type as the gradual development of cognitive 
deficits that include both types of memory impairment (ability to learn new material or recall 
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previous knowledge) and one type of cognitive disturbance: language disturbance, impaired 
ability to perform motor activity, failure to recognize objects, and disturbance in executive 
functioning such as planning or organizing. These deficits must result in an extreme 
impairment in social or occupational functioning which is a significant decline from the 
previous level of functioning and does not occur exclusively during delirium. To be 
categorized as Alzheimer’s disease dementia other disorders such as major depressive 
episode and schizophrenia must be accounted for to make sure they cannot explain the 
symptoms. Features that separate Alzheimer’s disease from other dementias are that it cannot 
be due to other central nervous system conditions such as Parkinson’s disease or 
cerebrovascular disease which can result in deficits in memory and cognition. It also cannot 
be due to substance-induced conditions or due to other systemic conditions that can cause 
dementia such as hypothyroidism and vitamin B deficiency (American Psychiatric 
Association, 2000). While the most recent version of the DSM (DSM-5) was published in 
2013 it is not likely to have been be used by the longitudinal studies in this meta-analysis 
(American Psychiatric Association, 2013).  
 A new meta-analysis should be done because the previous meta-analyses focused on 
the relationship between duration of sleep and cognitive decline (Liang & Ling-Bo & Hao, 
2018) or mild cognitive impairment (MCI) combined with dementia (Kim, et al., 2016: Wu 
& Sun & Tan, 2017). MCI is defined as the pre-clinical stage of dementia where an 
individual experiences slight impairment in one or more cognitive domains such as memory 
or language, but the person is still able to function independently. This differs from dementia 
where these cognitive domains must be impaired to the point that there is interference with 
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daily life. MCI can be diagnosed by an episodic memory test such as the word-list learning 
tests and by clinical judgment (Albert, et al., 2011). There has not been a meta-analysis 
which only includes studies that looked at dementia without MCI which may lead to different 
outcomes. This could occur because while people with MCI are more likely to develop 
dementia there are some individuals with MCI who return to normal cognition or remain 
mildly cognitively impaired (Kantarci, et al., 2009).  These previous meta-analyses also did 
not examine the relationship between change in duration of sleep and risk for dementia which 
is a growing body of research. As a result, a more recent meta-analysis to improve our 
understanding of the association between Alzheimer’s disease and sleep duration is needed. 
Public Health Significance 
If there truly is a causal association between abnormal sleep duration and cognitive 
decline, then sleep duration could be an important modifiable risk factor that could be 
targeted to improve the quality of life for the elderly (Youngstedt & Kripke, 2004). This 
could potentially be important information for public health programs because the percent of 
United State citizens who sleep 6 or less hours per day has increased from 28.6% in 2004 to 
32.9% in 2017. This corresponds to around 9 million adults and could lead to an increase of 
dementia cases if the association with short sleep duration holds true (Sheehan, et al., 2018). 
As a result, it is important to study why differences in study results have arisen. 
Hypothesis, Research Question, Specific Aims or Objectives 
The specific purpose of this study will be to expand the current understanding of the 
association between sleep and dementia to see if some consistency can be found in the 
conflicting studies. This was done by 1) performing a literature search to include publications 
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beginning from inception to January 2019 to try to increase statistical power; 2) generating 
summary effect measures for studies that have homogeneous results; and 3) identifying 
factors that could explain variation in effect measures across studies.   
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METHODS 
Study Design 
This study was a meta-analysis that followed the guidelines set by Preferred 
Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) (Moher, et al., 2009). 
The unit of analysis was each individual publication.  
Literature Search 
The articles were found by searching PubMed 
(https://www.ncbi.nlm.nih.gov/pubmed/), Embase (https://www.embase.com/) , Scopus 
(https://www.scopus.com) , and EBSCO (https://origin.ebsco.com/). In all four databases 
articles were identified by matching the articles’ title, keywords, and abstract to the following 
search terms: (change* in sleep duration” or “Sleep Duration”) and (Alzheimer* or 
dementia). The literature search included studies published up to January 20th 2019. In 
Embase, the exposure and outcome variables were searched separately then combined. The 
search term “Sleep time” was added for the exposure because it was a keyword that was 
specific to Embase and not used in PubMed and Scopus. The results were then limited by 
using the result filter for publication types which limited the results to “Articles”. The results 
were also refined in Scopus and EBSCO by limiting the document type to “Article”. There 
were no restrictions when searching for papers using PubMed. The papers from previous 
meta-analyses that follow the eligibility criteria, stated below, were also included. Duplicates 
were removed by using the citation manger RefWorks. 
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Data Collection:  
Two investigators independently selected the articles based on the following inclusion 
and exclusion criteria. Titles and abstracts were scanned to determine if they met the 
following eligibility criteria.  
 
Inclusion Criteria  
The articles included in the meta-analysis met the following inclusion criteria: 1) 
described a longitudinal study to allow the assessment of temporality 2) described the use of 
the following study designs: cohort, case-control, or clinical trial 3) assessed the relationship 
between the exposures sleep duration or change in sleep duration and the outcomes 
Alzheimer’s disease or dementia 4) diagnosed Alzheimer’s disease or dementia based on an 
established diagnostic criteria such as DSM-IV, medical records, or linkage to a national 
registry 5) provided enough data to calculate odds ratios (ORs), rate ratios (RRs), or hazard 
ratios (HRs) and the 95% confidence interval (CI) 6) the paper was written in English 7) the 
papers must be a published journal article and not a conference abstracts or excerpts.  
Exclusion Criteria 
1) Studies that included participants with Parkinson’s disease at baseline and in the 
outcome measure. This was done because sleep disorders (Chaudhuri & Schapira, 2009) and 
dementia (Hely, 2008) are non-motor symptoms associated with Parkinson’s disease. 
Another issue is that their level of cognition is different than the general population. 2) If the 
study subject was an animal model 3) Studies that had an outcome measure for MCI and 
dementia combined but not dementia independently 4) Studies that use napping duration as 
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the exposure of interest. This is because sleeping is fundamentally different from napping.  5) 
Articles based on a pilot study, when an article describing the full study is available.  
Quality Assessment 
Two investigators used the Newcastle-Ottawa quality assessment scale to 
independently perform the quality assessment. This assessment scale will be used since there 
are likely no clinical trials on this topic and because it was used by the previous three meta-
analyses (Kim, et al., 2016: Liang & Ling-Bo & Hao, 2018: Wu & Sun & Tan, 2017).This 
assessment scale has a maximum score of 9 stars and assesses quality based on the selection 
of cases and controls which has a maximum score of 4 stars and comparability of cases and 
controls which contributes a maximum of 2 stars. For case-control studies the quality is also 
based on the ascertainment of the exposed and non-exposed as well as the non-response rate 
which all contribute a maximum of 3 stars.  For cohort studies, the quality is based on the 
assessment of outcome, the time of follow up, and adequacy of follow up which contribute a 
maximum of 3 stars (Wells, et al., 2012). Disagreements on the score of each paper were 
settled by the investigators discussing their results to reach an agreement on the final score. 
There is currently no official threshold but a quality score of 0-3 stars will be considered low 
quality, 4-6 stars will be considered moderate quality, and 7-9 stars will be considered high 
quality (Liang & Ling-Bo & Hao, 2018). 
Data Extraction:  
Two investigators independently read the papers and extracted the variables of 
interest. The study characteristics: year of study, location of study (country),  study design 
(case-control, retrospective cohort, prospective cohort or clinical trial), number of 
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participants, percent of male participants, percent of drop outs, the confounders that were 
adjusted for and how they were measured, how the study handled cases of 
dementia/Alzheimer’s disease which developed in the first few years after baseline, the 
average age at baseline, the range of ages that was eligible for the study at baseline, duration 
of follow-up, and the number and percent of each ethnicity were extracted. The variables 
concerning the exposure: The cut-off for each category of sleep duration, the definition of 
sleep duration (e.g., 24 hours or night time sleep duration), the method that was used to 
measure duration of sleep, and number of participants in each sleep duration category were 
extracted. For the exposure variable “change in sleep duration”: the categories for change in 
sleep duration, time between previous sleep duration and current sleep duration, and number 
of participants in each change in sleep duration category were extracted. The variables 
concerning the outcome: the type of dementia (all cause dementia, Alzheimer’s disease, 
vascular dementia), the method that was used to determine Alzheimer’s disease or dementia 
and the number of cases and controls were extracted. The category dementia was labeled all 
cause dementia if there were no other categories of dementia present in the results. This was 
done to make the studies comparable and to reduce the number of outcome categories. The 
risk estimate (OR, HR, or RR) that adjusted for the most variables and its corresponding 95% 
confidence interval was also extracted. This was done because it can be assumed that 
adjustment will result in the true risk estimate for the exposure and outcome, making the risk 
estimates from different populations comparable even if they are obtained through different 
study methods. If there were more than three categories of sleep duration, then the ORs of all 
categories were kept. Sleep duration categories above the reference group were considered 
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long duration of sleep and sleep duration categories below the reference category were 
considered short duration of sleep. If the association between duration of sleep and dementia 
at different times points was reported then the risk estimate for each time point as well as the 
description of the time point was extracted. For the variable “Method of sleep ascertainment” 
if the question is simply “how many hours do you sleep” then it will be assumed that it is a 
24-hour period.  
 
Data Analysis 
All analyses were conducted using the software STATA version 15 (StataCorp, 
College Station, TX, USA). A p-value that was equal to or less than 0.05 indicated that the 
result was statistically significant. When analyzing the data, the effects of short duration of 
sleep and long sleep duration on the outcome were assessed separately. The analysis was also 
separated for the outcomes dementia, Alzheimer’s disease, and vascular dementia. This was 
done to prevent a unit-of-analysis error since there were several studies that looked at more 
than one subtype of dementia. As a result, if the analysis was not separated by outcome then 
the participants in the control groups would be counted more than once in an analysis since 
the same control group was used for each disease in one study. To maintain consistency, if 
there were more than 3 categories of sleep duration, the risk estimate from the lowest 
duration of sleep was used for assessment of short duration of sleep while the risk estimate 
from the highest duration of sleep was used for long duration of sleep. In the main analyses, 
if sleep was ascertained at two different ages in the same cohort, then the risk estimates for 
sleep ascertainment at around age 65 will be used because most studies ascertained sleep 
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around that age. A forest plot was created to visually compare and present the summary 
measures from each study. The effect measures OR, RR, HR and their 95% confidence 
intervals were used to calculate the I2 to evaluate the level of agreement between the studies 
(Higgins, et al., 2003).  
 The I2 was calculated under the fixed effects model for short duration of sleep 
because there appeared to be homogeneity. It was used because all studies categorized sleep 
in the same manner. The random effects model was used to assess long sleep duration since 
there were clear differences in how the studies characterized sleep. For example, the risk 
estimate used from Westwood et al. defined long sleep duration as 9 hours compared to less 
than 9 hours. This differed from the definition of long duration of sleep from other studies 
which compared the highest sleep category with the average category. While Westwood et al. 
did have a risk estimate which defined long duration of sleep in a similar manner as other 
studies it could not be used because it included participants with MCI at baseline. The 
random effects model was also used to assess prolonged and reduced sleep duration because 
there were very few studies, so they are not expected to include the true association.  
The I2 statistic was used because it can be used for comparing studies with different 
types of designs, outcome data, and sizes. The I2 values of 25%, 50%, and 75% were used to 
respectively represent low, moderate, and high heterogeneity. Values above 50% suggested 
statistical significance (Higgins, et al., 2003). Sensitivity analysis was performed to assess 
the contribution of each individual study to the magnitude of the overall summary estimates. 
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Publication Bias:  
To assess publication, bias an Egger’s regression test and a funnel plot were created. 
This was done because studies that suggests an association between the exposure and 
outcome may be more likely to be published then those that suggest no association which 
leads to publication bias. If no publication bias is present, then the plot should resemble a 
symmetrical inverted funnel because the plot indicates that precision increases as the study 
size increases. The Egger’s regression was also performed to validate the results from the 
funnel plot since there is criticism that asymmetry could be due to factors besides publication 
bias (Egger, et al., 1997). For example, greater effects may be seen in smaller intervention 
studies because they are more likely to have greater compliance.  
Meta-Regression and Subgroup Analysis 
A meta-regression was performed using the following pre-set variables: study design, 
sample size (less than 1000, 1000-3000, more than 3000), the number of sleep duration 
categories (3 or 5), definition of sleep duration (24-hour period or nocturnal sleep), type of 
cognitive disorder (dementia or Alzheimer’s disease), the number of cases (less than 500 or 
greater than 500),  race/ethnicity (white or non-white), gender (male, female, or both), 
duration of follow up (less than 10 years, 10-19 years, or more than 20 years), age at baseline 
(younger than 65 or 65 and older),  if they excluded people who developed a cognitive 
disorder after a certain number of years after baseline (yes or no), and the method of 
assessing sleep duration (self-report or questionnaire). The demographic variable age was 
chosen because the rate of dementia doubles every five years starting from age 65 (Evan, et 
al., 1989), ethnicity was selected because those who are non-Caucasian are more likely to 
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develop dementia then those who are Caucasian (Tang, et al., 1998), and gender because 
females are more likely to develop Alzheimer’s disease compared to men (Seshadri, et al., 
1997) while males are more likely to develop Lewy body dementia (Nelson et al., 2010).  
This was done to discover if any of these factors significantly affect the association between 
sleep duration and Alzheimer’s disease or dementia. However, the meta-regression should 
not have been considered because there were less than ten studies in each meta-regression 
(Higgins & Green, 2011).   
 After the study characteristics were abstracted, it was not possible to conduct a meta-
regression for study design since all the studies were cohort studies. There were several 
studies that did not describe the race/ethnicity of their cohort, so the studies were analyzed by 
the continent of the study cohort (Europe, Asia, or USA). The variables age of sleep 
ascertainment (early midlife or late-life) and MCI at baseline (yes or no) were included in 
further analysis. For age of sleep ascertainment, early mid-life was defined as obtaining data 
on sleep before age 60. If the study had both early mid-life and late-life risk estimates then 
the early mid-life was added to the analysis, so the analysis could reflect all findings. This 
variable was included because there were studies that assessed sleep duration after age 60 
while others assessed sleep around age 40 to 50. This subgroup was also included because 
beta-amyloid accumulation, one of the hypothesized biological mechanisms for Alzheimer’s 
disease, is believed to occur 20 years before the onset of dementia (Villemagne, et al., 2013).
 Having mild cognitively impaired individuals at baseline was originally an exclusion 
criterion. This is because a study found that shorter duration of sleep was protective for those 
who were cognitively impaired while those that had normal cognition were at greater risk for 
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cognitive decline (Johar, et al., 2016). Unfortunately, only three (Hahn et al., 2014:  
Westwood, et al., 2017: Bokenberger, et al., 2017) out of the eleven studies explicitly stated 
that they stratified by baseline cognitive status to separate those who are cognitively intact 
and those who are mild cognitively impaired. As a result, instead of only including these 
three studies in the meta-analysis a subgroup analysis was conducted to determine if studies 
that included MCI at baseline were more likely to have significant results than studies that 
didn’t include MCI at baseline. This was done by obtaining a summary effect estimate from 
studies that did not include MCI participants at baseline and a summary effect estimate from 
studies that had MCI participants at baseline.  
 
Human Subjects, Animal Subjects, or Safety Considerations  
There was no data obtained from human subjects since this study was a meta-analysis 
of published literature. The statistical analysis for this study was done using the effect 
measures calculated from group data that were extracted from each individual study.  
RESULTS 
Literature Search  
 
The initial literature search identified 371 papers from PubMed, 624 papers from 
Embase, 20 from Scopus, 38 from EBSCO, and 28 citations from the previous three meta-
analyses. (Kim, et al., 2016: Liang & Ling-Bo & Hao, 2018: Wu & Sun & Tan, 2017). After 
removing the 217 duplicates there were 573 articles left. After screening the titles and 
abstracts of the articles there were 48 articles left that were fully read to assess for eligibility. 
The 525 publications were excluded because they were not in English, used an animal model, 
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were not an article, were a review, or they clearly did not have the outcome or exposure of 
interest which made it irrelevant. Once this was completed, there were 11 studies left for 
quantitative synthesis after 36 articles were excluded for including the dementia/MCI 
outcome, being a cross-sectional study, or reporting dementia mortality without dementia 
incidence. The results of the literature search are presented in Figure 1. These eleven studies 
were considered high quality based on the Newcastle-Ottawa quality assessment scale.   
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Figure 1. Results of the literature search. This flow diagram shows the process used to 
determine the final studies from all the studies that were found in the literature 
search.  
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Study Characteristics  
 All 11 studies consisted of cohort studies from 2009 to 2018 and were considered 
high quality by the independent investigators based on the Newcastle-Ottawa quality 
assessment scale (Appendix F).  These studies had an average follow-up time of 14.9 years 
and a total of 48,360 participants. However, only 35,963 participants had data specific for 
sleep duration and 26,344 participants of these participants were included in the analysis 
portion of this meta-analysis. This drop-in participants from 48,360 to 26,344 occurred 
because the studies analyzed other sleep characteristics so there were some participants 
without information on sleep duration. The drop was also due to the use of only the highest 
and lowest sleep duration category in relation to the reference category. For the definition of 
sleep, there were four studies that defined sleep as night time sleep using a question such as 
“how many hours do you usually sleep at night” while seven studies defined sleep as the 
amount of sleep in a day by asking questions such as “how many hours on average do you 
sleep per day” (Appendix A). Three of the studies looked at change in sleep duration while 9 
studies looked at sleep duration. Out of the studies that looked at sleep duration five had the 
outcome Alzheimer’s disease, 6 had the outcome dementia, and one had the outcome 
vascular dementia. However, three of these studies categorized dementia as all-cause 
dementia. From the studies that assessed change in sleep duration all three assessed the 
outcome dementia while only 2 assessed Alzheimer’s disease. There were 3 studies that 
defined sleep duration as sleep in a 24-hour period and 7 studies that defined sleep duration 
as time in bed. There were five studies which included assessment of sleep duration during 
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mid-life (35-64) and six studies which assessed sleep duration during late life (65+). The 
study characteristics can be found in Error! Not a valid bookmark self-reference.. 
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Table 1 Study Characteristics. This table displays the key characteristics of the studies that were used in the meta-regression as well as the 
subgroup analysis.                                                                                                                                                             
 Adjusted variables: Age (1) Sex (2) Education (3) Heart disease (4) Blood pressure (5) Hypertension  (6) Stroke (7) Chronic obstructive pulmonary disease (8) Total supernatant cholesterol (9) Low-density 
lipoprotein (10) High-density lipoprotein (11) hsCRP (12) Hyperlipidemia (13) Hypercholesterolemia (14) Diabetes (15) Obesity (16) Body mass index (17) Cancer history (18) APOE (19) Homocysteine (20) C-
reactive protein (21) Smoking (22) Alcohol (23) Physical activity (24) Mental health (25) Depression (26) Psychological distress (27) Hopelessness (28) Pain (29) Living arrangement (30) Life satisfaction (31) 
Medication (32) Physical functional dependence (33) Night work status (34) Coffee consumption (35) Center (36) Follow-up time (37) Examination year (38) 
AD: Alzheimer’s Disease (ref): Reference group NA: Not available  
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Sleep Duration and Dementia  
 There were 9 studies that studied the association between sleep duration and a form of 
dementia. All 9 studies accessed the association between long sleep duration and a form of 
dementia while only 8 included the risk estimates for the association between short sleep 
duration and a form of dementia.  
Short duration of sleep was defined as less than 5 hours of sleep in 2 studies, less than 
6 hours in 2 studies, less than 6.5 hours for one study, and less than 7 hours for 2 studies. For 
short duration of sleep, all-cause dementia had a summary risk estimate of 1.18 (CI: 0.94-
1.42) and an I2 of 31.6% (p=0.199) (Figure 2). Alzheimer’s disease had a summary risk 
estimate of 1.01 (CI: 0.92-1.09) and an I2 of 10.0% (p=0.343) (Figure 2). There were only 
two studies of non-Alzheimer’s dementia (1.08 CI: 0.30-1.86) and one study of vascular 
dementia (4.04 CI: -1.61-9.69) so a summary risk estimate could not be calculated for these 
two forms of dementia (Figure 2). The p-values of the meta-regression were all above the 
0.05 significance level. The subgroup analysis found that all variables of interest contained 1 
in their confidence interval, except for dementia studies with both genders in their cohort 
(1.43 CI: 1.03-1.83). The results of the meta-regression and subgroup analysis can be found 
in Appendix C. When determining publication bias in the studies that assessed the 
association between short sleep duration and incident dementia the Egger’s regression had a 
p-value of 0.799 and the funnel plot was symmetrical (Appendix E). For studies that assessed 
the association between short sleep duration and Alzheimer’s disease the Egger’s regression 
had a p-value of 0.003 and an asymmetrical funnel plot (Appendix E). 
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Figure 2 Forest plot for short duration of sleep and the different forms of dementia. Using the 
fixed effects model.  The risk estimates for each individual study represent the 
shortest duration of sleep compared to the reference group.  
 
 Long duration of sleep was considered as more than 9 hours of sleep in 6 studies, 
more than 8 hours of sleep in one study, and 10 or more hours of sleep in one study. 
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Dementia had a summary risk estimate of 1.19 (CI: 0.90-1.48) and an I2 of 37.1% (p=0.146) 
(Figure 3). Alzheimer’s disease had a summary risk estimate of 1.32 (CI: 0.92-1.72) and an I2 
of 16.3% (p=0.065) (Figure 3. Forest plot for the association of long duration of sleep and the 
different forms of dementia. Figure 3). The summary effect measures for non-Alzheimer’s 
disease dementia was 1.33 (CI: 0.36-2.30). There was only one study that assessed vascular 
dementia. The results of the meta-regression revealed that all variables of interest had p-
values greater than 0.05 except for the variable time of follow-up (p=0.02) for dementia 
(Appendix D). The subgroup analysis found that most of the variables of interest contained 
one in their confidence interval. However, the confidence interval did not include one for 
studies that assessed dementia that had both genders in the cohort (1.22 CI: 1.04-1.39), 
duration of follow up that was less than 10 years (2.54 CI: 1.07-4.00), duration of follow up 
was between 10-19 years (1.21 CI: 1.03-1.38), ascertained sleep at early mid-life (1.27 CI: 
1.02-1.53), and did not include mild cognitively impaired individuals at baseline (1.19 
CI:1.01-1.38). For studies that assessed Alzheimer’s disease, those that defined sleep as time 
in 24-hour sleep (1.79 CI: 1.11-2.47) and had less than 200 cases of Alzheimer’s disease 
(1.75 CI: 1.16-2.35) had confidence intervals that did not include 1. The results of the meta-
regression and subgroup analysis can be found in Appendix D. The studies that focused on 
long duration of sleep and dementia had an Egger’s regression p-value of 0.201 and a 
symmetrical funnel plot (Appendix E). The studies that focused on long duration of sleep and 
Alzheimer’s disease had a p-value of 0.022 and an asymmetrical funnel plot (Appendix E).  
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Figure 3. Forest plot for the association of long duration of sleep and the different forms of 
dementia. Using the random effects model.  
Change in Sleep Duration  
 There were 3 studies that studied the association between change in sleep duration 
and a form of dementia.  
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Sleep reduction was defined as two or more hours of reduced sleep in two studies and 
a change of sleep duration from more than 9 hours to less than 9 hours in one study. The 
association between reduction of sleep duration and dementia had a summary risk estimate of 
1.19 (CI: 0.79-1.68) and an I2 of 21.9% (Figure 4). For Alzheimer’s disease, the summary 
risk estimate was 1.65 (CI: 0.67-2.63) and I2 was 0% (Figure 4). When assessing the 
publication bias of these three studies the Egger’s regression p-value was 0.497 and the 
funnel plot was symmetrical. When assessing publication bias in studies that assessed the 
association between reduced sleep and dementia the funnel plot was symmetrical. There was 
only one study that assessed the association between reduced sleep and Alzheimer’s disease 
(Appendix E). There was insufficient data for a meta-regression.  
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Figure 4. Forest plot for the association between sleep reduction and the different forms of 
dementia. Using the random effects model. 
Increase in sleep duration was defined as an increase of sleep by 2 hours or more in 
two studies while one study defined increased sleep as a change of sleep duration from less 
than 9 hours of sleep to 9 or more hours of sleep (Error! Not a valid bookmark self-
reference.). There were two studies that looked at the association between increase in sleep 
duration and incident dementia which resulted in a summary risk estimate of 2.11 (CI: 1.46- 
2.77) and an I2 of 0% (Figure 5). For Alzheimer’s disease, a summary risk estimate could not 
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be calculated because there was only one study that assessed this association. Publication 
bias could not be assessed for increase in sleep duration and Alzheimer’s disease because 
there was only one study (Appendix E). The funnel plot for studies that assessed the 
association between increase in sleep and dementia was symmetrical (Appendix E). There 
was insufficient data for a meta-regression.  
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Figure 5. Forest plot for the association of increase of sleep duration and the different forms 
of dementia.  Using the random effects model. 
Sensitivity Analysis  
 For the association between short duration of sleep and dementia the removal of the 
study Sindi et al. gave a summary effect measure of 1.2741 (CI: 1.0091-1.5394). For the 
association between long duration of sleep and dementia the removal of the study Luojus et 
al. gave a summary effect measure of 1.2736 (CI: 1.0180-1.5291) while the removal of any 
of the other studies still gave a summary effect measure with a CI which contained one. For 
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the association between short duration of sleep and Alzheimer’s disease the removal of any 
single study did not change the association and all confidence intervals still contained one.  
For the association between long duration of sleep and Alzheimer’s disease the removal of 
the study Larsson et al. gave a summary effect measure of 1.7516 (CI: 1.1567-2.3464) while 
the removal of other studies did not shift the risk estimate’s confidence interval to make it 
contain one. The results of the sensitivity analysis can be found in Error! Reference source 
not found. and Error! Reference source not found..  
 
Table 2. Sensitivity Analysis: The summary effect measure after the removal of a single 
study. This sensitivity analysis showed the effect of removing a single study on the overall 
summary effect measure for sleep duration and incident dementia or Alzheimer’s disease. 
Original represents the original summary effect measure and confidence interval for each 
association.  ES represents effect measure while CI represents confidence interval. Red* 
indicates statistical significance. 
 
DISCUSSION 
Sleep Duration  
The results from the meta-analysis indicate that there is no significant association 
between short or long sleep duration and any form of dementia. This differs from previous 
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meta-analyses that found a summary effect measure that suggested association between 
dementia and long duration of sleep (1.42 CI: 1.15-1.77) (Kim et al., 2016) and between 
Alzheimer’s disease and both short (1.64 CI: 1.05-2.54) and long (2.19 CI: 1.08-4.46) sleep 
duration (Wu & Sun & Tan, 2018). In addition, the dose-response meta-analysis, performed 
in the two most recent meta-analyses, found that individuals reporting either long duration of 
sleep or short duration of sleep were more likely to develop dementia/MCI than those with 
normal sleep (Liang & Ling-Bo & Hao, 2018: Wu & Sun & Tan, 2018).  
The difference in results for the association between Alzheimer’s disease and sleep 
duration may be due to the inclusion of new studies that were not published by the time Wu 
et al. completed their literature search. This is supported by the sensitivity analysis which 
found that the association between long duration of sleep and Alzheimer’s disease would 
become statistically significantly (1.7516 CI: 1.1567-2.3464) if Larrson, et al. was removed 
(Error! Reference source not found.).  This study was not in the previous meta-analyses 
and contributed the greatest weight (28.63%) to the summary risk estimate for the association 
and made it statistically insignificant (Figure 3). This study had one of the longer follow-up 
times, 16 years, but what distinguishes it from other studies is that they accounted for the 
reverse causation effect by excluding cases of Alzheimer’s disease five or ten years after 
baseline. This time period is longer than the other studies which excluded cases up to three 
years after the study was initiated. This study also had the largest sample size and highest 
number of Alzheimer’s disease cases when compared to other studies that assessed sleep 
duration and Alzheimer’s disease.  
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Another explanation is that studies that looked at the Alzheimer’s disease outcome 
and defined sleep duration by a 24-hour period were more likely to see significant results. 
This was shown by subgroup analysis which found that studies that looked at the association 
between long duration of sleep and Alzheimer’s disease and defined sleep duration in a 24-
hour period had a summary risk estimate of 1.79 (CI: 1.11-2.47), while studies that used time 
in bed had a weaker risk estimate that was statistically non-significant (1.07 CI: 0.76-1.38) 
(Appendix D).  This could occur because a study of total daily sleep time found that people 
who self-report long duration of sleep are more likely to complain of disrupted and poor 
sleep than those who sleep 7-8 hours daily (Grandner & Kripke, 2004).  As a result, a sleep 
duration defined by a 24-hour hour period could capture sleep fragmentation or low-quality 
sleep which have been associated with increased risk of dementia (Lim, et al., 2013). 
However, the more plausible explanation is that Larsson et al. defined sleep as time in bed so 
when this study was separated from studies that defined sleep duration in a 24-hour period it 
results in a significant finding.  
The removal of Sindi et al. resulted in a significant summary effect measure between 
short duration of sleep and dementia (1.2741 CI: 1.0091-1.5394). The likely explanation is 
that it was the only study to show a protective risk ratio (0.74 CI: 0.36-1.53) and it 
contributed the third most weight (1.83%) in the dementia subcategory (Figure 2). While this 
sample size was less than a quarter of the sample size of the other studies in the subgroup it 
did have a smaller variance, which could be attributed to a greater number of cases. 
However, this can only be assumed since the number of Alzheimer’s disease and dementia 
cases was never stated.   
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The association between dementia and long duration of sleep became significant with 
the removal of Luojus et al. which resulted in a summary effect measure of 1.2736 (CI: 
1.0180-1.5291) (Error! Reference source not found.). This was a study that was published 
after the Kim et al. study but the impact of this study was surprising because this study only 
carried 18.67% of the weight while Bokenberger et al. carried 36.49% of the weight. 
However, it was also the only study that found that long duration of sleep was protective for 
dementia (0.83 CI: 0.55-1.23) so its removal would likely shift the summary risk estimate to 
the right. (Figure 3). It was also the only study that had an all-male cohort which explains the 
results of subgroup analysis for gender (Appendix D). The study was also the only one that 
had a follow-up longer than 20 years. Thus, its separation resulted in the subgroup analysis 
finding that studies with less than 10 years of follow up (2.54 CI: 1.07-4.00) and follow up 
between 10 to 19 years (1.21 CI: 1.03-1.38) were statistically significant (Appendix D). As a 
result, it is likely the reason why the subgroup analysis and meta-regression suggested that 
follow-up time could explain the heterogeneity and insignificant association for long duration 
of sleep and dementia but not for other associations.   
Change in Sleep Duration  
This is the first meta-analysis to compile the results of studies that looked at the 
association between change in sleep duration and the different forms of dementia. While 
sleep reduction did not show any significant association with any form of dementia the 
association between increase in sleep and dementia was found to be statistically significant 
(2.11 CI: 1.46-2.77) (Figure 5). However, there were only two studies that assessed the 
association between prolonged sleep duration and dementia which means that there is likely 
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publication bias. However, the heterogeneity between the two studies was zero (Figure 5). 
While these two studies had similar study characteristics for length of follow up and method 
of sleep ascertainment they did have differences in how they categorized change in sleep and 
their definition of sleep. The study Westwood et al. defined increase in sleep duration as 
sleeping less than nine hours 13 years before baseline then more than 9 hours at baseline. The 
study Lu et al. defined sleep increase as a 1-hour increase in sleep or more than 2 hours of 
increase in sleep (Error! Not a valid bookmark self-reference.). However, for this analysis 
only the risk estimate from the 2 hours of increase in sleep category was used.  
To the authors’ knowledge, there is no well accepted hypothesis for why prolonged 
sleep duration could be associated with dementia incidence even though biological 
mechanisms have been proposed for reduced, short, and long duration of sleep. Reduced 
sleep and short duration of sleep are believed to prevent beta-amyloid clearing which causes 
beta-amyloid plaque build-up which is a defining characteristic of Alzheimer’s disease 
(Spira, et al.,2013). Long duration of sleep has been associated with arterial stiffness 
(Niijima, et al., 2016) and blood pressure variability (Nagai, et al., 2017) which increases the 
risk of cardiovascular disease which is a known risk factor for dementia. However, one 
possible explanation is that prolonged sleep could be a marker for early neurodegeneration 
and not an actual cause of dementia (Westwood, et al., 2017). Another explanation is that the 
immunomodulators such as interleukin-6 and C-reactive protein which have been associated 
with dementia (Akiyama, et al., 2000), have also been shown to increase sleep duration and 
fragmentation during infections so the relationship may be bi-directional (Imeri & Opp, 
2009).  
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Test of Heterogeneity  
When assessing heterogeneity, The I2 statistics suggested low heterogeneity for short 
sleep duration and dementia (31.6%) and Alzheimer’s disease (10.0%) (Figure 2). It also 
suggested low heterogeneity for long sleep duration and the outcomes dementia (I2 =37.1%) 
and Alzheimer’s disease (16.3%) (Figure 3). The meta-regression for long duration of sleep 
and dementia suggest that the low heterogeneity could be explained by length of follow-up 
(p=0.002). When the subgroup analysis was conducted for this association, the I2 statistics 
were reduced to 0% when separating the results by duration of follow up between 1-9 years, 
10-19 years, and 20+ years. (Appendix D). 
Publication Bias 
  Publication bias was expected in this meta-analysis because it included very few 
studies. However, the Egger’s regression and funnel plot only indicated publication bias in 
the 5 studies that assessed the association between sleep duration and Alzheimer’s disease 
and not the 7 studies that assessed the association between sleep duration and dementia 
(Appendix E). The reason why no publication bias was detected could be a result of the small 
number of studies which prevented the test from determining true asymmetry due to low 
power (Higgins & Green, 2011).  
Subgroup Analysis  
 Due to the small number of studies the results from the subgroup analysis should be 
interpreted with caution. This is because when a variable was significant it was often only 
significant for one or two of the associations but not for others. The variables with the most 
consistency were gender and sleep duration categories. When subgrouping by gender, the 
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summary effect estimate was significant in studies which had a mixed gender cohort that 
assessed both long and short sleep duration and dementia. However, it is surprising that this 
result was seen in dementia and not Alzheimer’s disease because females are more likely to 
develop Alzheimer’s disease than males (Seshadri, et al., 1997), while males are more likely 
to develop dementia with Lewy bodies than females (Nelson, et al., 2010). There was no all-
female cohort and only one male cohort, so this assumption cannot be verified. When 
subgrouping by duration of follow-up, the summary effect estimate was significant in studies 
that assessed long duration of sleep and dementia with 1-9 years of follow up (2.54 CI: 1.07-
4.00) and 10-19 years of follow up (1.21 CI:1.03-1.38).  
The results of the subgroup analysis for the inclusion of MCI at baseline were 
surprising because the summary effect measure for studies of the association of dementia and 
long sleep duration that did not have MCI at baseline was significant, while the studies that 
possibly had MCI at baseline didn’t have a statistically significant summary effect measure 
(Appendix D). This was unexpected because mild cognitively impaired individuals are more 
likely to develop dementia. As a result, the subgroup analysis of studies that included MCI 
participants should have had significant results rather than the studies that did not include 
participants with MCI at baseline. However, this finding could be explained by the 
Bokenberger, et al., 2017 study which found an association between long duration of sleep 
and dementia because of their large number of participants and cases.   
It is hypothesized that beta-amyloid accumulation can begin up to 20 years before the 
onset of Alzheimer’s disease symptoms (Villemagne, et al., 2013). Since it is a suggested 
biological pathway that links sleep duration to dementia it is important for sleep duration to 
36 
 
be assessed before this accumulation is believed to begin. In the current research, only four 
of the eleven studies have the capability for this assessment because they have a 
measurement of sleep duration during mid-life (Larsson, et al., 2018: Luojus, et al., 2017: 
Virta, et al., 2013: Westwood, et al., 2017). The summary effect estimate of these studies 
suggests that there is no association between sleep duration and any form of dementia 
(Appendix C). As a result, these results suggest that beta-amyloid accumulation due to short 
sleep duration may not be a pathway between sleep and Alzheimer’s disease since early mid-
life sleep duration does not seem to increase disease risk. However, there were very few 
studies that studied sleep between ages 40-55 so more studies need to be done to determine if 
this is the case.  
CONCLUSION 
This meta-analysis suggests that there is no association between duration of sleep and 
any form of dementia which differs from the findings of previous meta-analyses. The 
analysis suggests that the difference could be a result of new studies that have longer follow 
up time and to differences in sleep definition. This meta-analysis did find that the association 
between prolonged sleep duration and dementia was statistically significant. However, this 
association needs to be verified by more research since only 2 studies have looked at this 
association.  
The major limitation is that this study included very few studies. The funnel plots and 
Egger's regression suggested publication bias which means that the inclusion of new studies 
could possibility change the associations found in this study. The small number of studies 
also made the interpretation of subgroup analyses difficult because the small number of 
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studies increased the chance of seeing an association even when there was truly no 
association. It was difficult to discern if the significant result of the subgroup analysis was 
due to the actual variable or simply due to chance because of other variables that were 
included in the same paper. As a result, the conclusions from this study should be taken with 
caution. Another major issue is that most of these studies used self-reported data for sleep 
duration. While some studies attempted to use multiple questions to obtain data on sleep 
duration others simply asked, “how much sleep do you normally get” (Appendix A). Thus, it 
is likely that most studies suffer from reporting bias.  
Another limitation of this study and the previous meta-analyses is the use of only the 
risk estimates from the longest and shortest sleep categories (Appendix A). This decreased 
the power of the findings because there were less participants in these categories and thus 
fewer cases. However, since these risk estimates were mostly hazard ratios there was no 
method available to combine categories, so this method was used at the recommendation of 
the Cochrane handbook (Higgins & Green, 2011).  
The strength of this study is that it included more studies than the previous meta-
analyses. This meta-analysis also only included studies that looked at the various forms of 
dementia without MCI. These studies had longer lengths of follow-up than the studies in the 
previous meta-analyses and they included non-Caucasian groups which was a limitation of 
previous meta-analyses. Even though the major limitation was the small number of studies it 
did allow the investigators to thoroughly read and understand all articles to try to find 
explanations for the differences in study results.  
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Recommendations for future studies would be to create a more accurate method for 
sleep duration ascertainment. While polysomnography would be the gold standard it would 
be difficult and costly for large cohorts an alternative might be fitness trackers that can 
record the duration of sleep. However, a more reasonable method would be to use multiple 
questions to obtain more accurate measures of sleep since many of these studies only used 
one question to determine sleep duration (Appendix A). Other recommendations include 
studying the effects of sleep duration at mid-life since the hypothesized beta-amyloid 
accumulation pathway is believed to start 20 years before the actual onset of Alzheimer’s 
disease and for studies to stratify data on baseline cognitive status.  
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APPENDICES 
 
Appendix A. Characteristics and risk estimates of sleep categories. The question used to 
determine the sleep duration exposure, the number of participants per sleep category, and the 
risk estimates associated with each categories of sleep duration.  
Bold: Represents the risk estimate that was used in the analyses, Red: Represents results of 
the specific study that were significant, Ref: Reference group, LC: Left censored by three 
years, W/MCI: With MCI participants, NA: Not available, PY: Person Years  
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Appendix B. Sensitivity analysis: These graphs show visualization of the summary effect 
measure when the specific study is excluded a) The summary effect measure for short sleep 
duration and Alzheimer’s disease b) The summary effect measure for long duration of sleep 
and Alzheimer’s disease c) The summary effect measure for short duration of sleep and 
dementia d) the summary effect measures for long sleep duration and dementia.  
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Appendix C. Subgroup analysis and meta-regression for short duration of sleep. Red* 
indicates statistical significance. ES represents the effect size for the association based on the 
subgroup. The I2 represents the heterogeneity and P (Heterogeneity) is the p-value associated 
with the percent heterogeneity from the I2 statistics for the specific sub-group. The P (Meta-
regression) represents the p-value for the meta-regression of the specific variable.  
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Appendix D. Subgroup analysis and meta-regression for long duration of sleep. Red* 
indicates statistical significance. The I2 represents the heterogeneity and P (Heterogeneity) is 
the p-value associated with the percent heterogeneity from the I2 statistics for the specific 
subgroup. The P (Meta-regression) represents the p-value for the meta-regression of the 
specific variable.  
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Appendix E. The results of the funnel plots to determine publication bias. A)The funnel plot 
representing studies that assessed the assocation between Alzheimer’s disease and short 
duration of sleep. B) The funnel plot representing studies that assessed the assocation 
between Alzheimer’s disease and long duration of sleep. C) The funnel plot representing 
studies that assessed the assocation between dementia and short duration of sleep D) The 
funnel plot representing studies that assessed the assocation between dementia and long 
duration of sleep. E) The funnel plot representing studies that assessed the assocation 
between decreased sleep and Alzheimer’s disease. F) The funnel plot representing studies 
that assessed the assocation between increase in sleep and Alzheimer’s disease. G) The 
funnel plot representing studies that assessed the assocation between decreased sleep and 
dementia. H) The funnel plot representing studies that assessed the assocation between 
increase in sleep and dementia. 
Study  Quality 
Score  
Selection  Comparability  Outcome 
Benito-Leon et al., 
2009 
9 **** ** *** 
Virta et al., 2013 8 *** ** *** 
Hahn, et al., 2014 8 *** ** *** 
Bokenberger et al., 
2017 
8 *** ** *** 
Luojus et al., 2017 8 *** ** *** 
Westwood et al., 2017 8 *** ** *** 
Larsson et al., 2018 8 *** ** *** 
Lu et al., 2018 8 *** ** *** 
Lutsey et al., 2018 9 **** ** *** 
Ohara, et al., 2018 8 **** * *** 
Sindi et al., 2018 8 *** ** *** 
Appendix F. Quality scores of the eleven studies using the Ottawa Quality Assessment Scale. 
A quality score of 0-3 represents a low-quality score, 4-6 represents moderate quality, and 7-
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9 represents high quality. The quality score is made up scores from how they selected their 
sample (0-4 stars), how the study was comparable to other studies based on variables they 
adjusted for (0-2 stars), and factors concerning the outcome (0-3 stars).  
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